What is Rite Aid’s Current Revenue & EBITDA Breakdown?

+262.59%
Upside
0.65
Market
2.35
Trefis
RAD: Rite Aid logo
RAD
Rite Aid

Rite Aid derives ~60% of its revenue from Prescription Drugs Division

cvs-q1

Have more questions about Rite Aid (NYSE: RAD)? See the links below:

Relevant Articles
  1. Rite Aid Stock Could Move Higher From $10
  2. Key Takeaways and Trends From Rite Aid’s Q2 FY’19 Earnings
  3. How Has Rite Aid Performed In FY 2018?
  4. What Are The Chances Of Rite Aid’s Recovery From Its Current Slump?
  5. Why Is Rite Aid’s Stock Performing So Poorly?
  6. Walgreens And Rite Aid Deal Is Back On Track And Both The Companies Are Expected To Gain

Notes:

1) The purpose of these analyses is to help readers focus on a few important things. We hope such lean communication sparks thinking, and encourages readers to comment and ask questions on the comment section, or email content@trefis.com.
2) Figures mentioned are approximate values to help our readers remember the key concepts more intuitively. For precise figures, please refer to our detailed analysis for Rite Aid

View Interactive Institutional Research (Powered by Trefis):

Global Large Cap | U.S. Mid & Small Cap | European Large & Mid Cap

More Trefis Research